Hospira Logo (Tazicef 01)
Tazicef Injection, Powder, For Solution
Product Images NDC 0409-5084
7 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tazicef (NDC 0409-5084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tazicef Structural Formula (Tazicef 02)
Chemical structure of the active ingredient for Tazicef, showing a complex molecular diagram including nitrogen, sulfur, carbon, oxygen atoms, and a pyridinium moiety with a pentahydrate notation (5H2O).*
Hospira Logo (Tazicef 03)
Principal Display Panel (2 gram Vial Tray Label)
Label for Tazicef 2 g/vial, ceftazidime for injection, USP, intended for intravenous use. The label indicates it is a single-dose vial, prescription-only, manufactured by Hospira, Inc., with detailed reconstitution instructions and storage conditions. The label also includes an NDC number and manufacturer information for Sandoz GmbH.*
Principal Display Panel (1 gram Vial Tray Label)
Label for Tazicef 2 g vial, ceftazidime for injection, USP. The label states it contains 10 single-dose vials. It includes storage information (20°C to 25°C), usage instructions, and manufacturer details: Sandoz GmbH for Hospira, Inc. The label also shows relevant barcodes and product identifiers.*
Tazicef 06
Label for Tazicef 1 gram vial containing ceftazidime for injection, USP. This single-dose vial is for intravenous or intramuscular use and is labeled for Rx only. The label includes dosage information and storage instructions. Manufactured by Hospira, Inc.*
Tazicef 07
Tazicef 1 g/vial ceftazidime for injection, USP packaging label. The label indicates the product is available as single-dose vials (25 count) distributed by Hospira, Inc. It includes storage instructions at 20°C to 25°C, reconstitution details, and dosage guidance for adults. The vial contains ceftazidime pentahydrate equivalent to 1 gram of ceftazidime, along with sodium carbonate. Manufactured by Sandoz GmbH for Hospira, made in China, with barcodes and expiration/lot information shown.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
